Clinical trial
Hemostatic Powder Following Injection Therapy Versus Conventional Dual Therapy for Endoscopic Hemostasis for Non-variceal Upper Gastrointestinal Bleeding
NCT02717416 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemostatic Powder Following Injection Therapy Versus Conventional Dual Therapy for Endoscopic Hemostasis for Non-variceal Upper Gastrointestinal Bleeding
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- May 30, 2021
- Enrollment
- 226 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
upper gastrointestinal bleeding